Hevert Contrallergia

Product NDC
54532-0035
Requested package NDC
54532-0035-4
11-digit product format
545320035
Labeler code
54532
Product ID
54532-0035_4b4150e5-df5d-4614-b0f0-f26e65b11ef6
Type
HUMAN OTC DRUG
Nonproprietary name
APIS MELLIFERA, GALPHIMIA GLAUCA WHOLE, POTASSIUM DICHROMATE, TEUCRIUM MARUM TOP, and VERBASCUM DENSIFLORUM Flowering TOP
Dosage form
TABLET
Route
ORAL
Labeler
Hevert Arzneimittel GmbH & Co KG
Marketing category
UNAPPROVED HOMEOPATHIC
Marketing start
2019-12-01
Marketing end
0000-00-00
Substance
APIS MELLIFERA; GALPHIMIA GLAUCA WHOLE; POTASSIUM DICHROMATE; TEUCRIUM MARUM TOP; VERBASCUM DENSIFLORUM FLOWERING TOP
Active strength
4 [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1
Pharmacologic classes
Allergens [CS], Bee Venoms [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Standardized Insect Venom Allergenic Extract [EPC]
NDC exclude flag
No
Listing certified through
2023-12-31
Current FDA listing
Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 1 matching rows.

Dataset, Scope, Product NDC table
DatasetScopeProduct NDCPackage NDCCodeStatusReporting periodSource date
excluded packagepackage54532-003554532-0035-4DDiscontinued by firm2026-11-19

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 9 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Snapshot, Source SHA-256 table
Captured / source dateSnapshotSource SHA-256
2025-12-14 17:58 UTC · source 2025-12-05d630ba8d3edf…732f749b63fb…
2025-08-27 00:01 UTC · source 2025-08-26f5e01cc5f278…a2eaf40c39c3…
2025-04-01 02:39 UTC · source 2025-03-312ef7874e63bc…57b86245f4fa…
2025-03-28 20:22 UTC · source 2025-03-28a1b67e2a42f9…c4cf2c586c0d…
2025-03-22 03:12 UTC · source 2025-03-21cfe11265f3b6…090c488252e2…
2025-03-10 12:48 UTC · source 2025-03-10cdf11ea48f46…ba0047e9e063…
2025-02-02 03:52 UTC · source 2025-01-31302b2466d912…e7b80fea0513…
2025-01-20 13:05 UTC · source 2025-01-20ed331223b511…672a5bd82f5f…
2025-01-11 03:41 UTC · source 2025-01-100efc9e666f02…f202fb6c5f17…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
54532-0035-45453200350410 BLISTER PACK in 1 CARTON (54532-0035-4) > 10 TABLET in 1 BLISTER PACK10 blister pack2019-12-010000-00-00NoNoCurrent